Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RZLT
RZLT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RZLT News
Rezolute to Present Research Findings at ENDO Conference
Jun 04 2026
Newsfilter
ABIVAX and Others See Significant Stock Gains
Jun 04 2026
NASDAQ.COM
Rezolute Stock Rises Following Upgrade by Citizens JMP Securities
Jun 03 2026
seekingalpha
Wall Street's Latest Ratings Overview
Jun 03 2026
CNBC
Rezolute Updates Late-Stage Trial Progress for Ersodetug
Jun 02 2026
seekingalpha
Rezolute Reports Q3 Earnings Beat Expectations
May 12 2026
seekingalpha
Rezolute Presents New Data on Ersodetug Study Outcomes
May 01 2026
Newsfilter
Rezolute's Positive FDA Meeting Outcomes for sunRIZE Program
Mar 25 2026
Newsfilter
Rezolute Shares Rise After Positive FDA Meeting Outcome
Mar 24 2026
seekingalpha
Faruqi & Faruqi Investigates Investor Losses in Rezolute
Mar 05 2026
PRnewswire
Faruqi & Faruqi Investigates Investor Losses in Rezolute
Feb 28 2026
PRnewswire
Faruqi & Faruqi Investigates Rezolute Investor Losses
Feb 26 2026
Globenewswire
Faruqi & Faruqi Investigates Rezolute Losses for Investors
Feb 15 2026
Globenewswire
Faruqi & Faruqi Investigates Investor Losses in Rezolute
Feb 13 2026
PRnewswire
Rezolute Reports Q2 Loss, Downgrades Ahead
Feb 12 2026
seekingalpha
Rezolute Shares Plunge 90% After Phase 3 Trial Failure
Feb 09 2026
Globenewswire
Show More News
